1. Home
  2. W vs BBIO Comparison

W vs BBIO Comparison

Compare W & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wayfair Inc.

W

Wayfair Inc.

HOLD

Current Price

$92.82

Market Cap

11.7B

ML Signal

HOLD

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$78.10

Market Cap

12.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
W
BBIO
Founded
2002
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7B
12.7B
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
W
BBIO
Price
$92.82
$78.10
Analyst Decision
Buy
Strong Buy
Analyst Count
28
25
Target Price
$105.82
$86.33
AVG Volume (30 Days)
3.4M
2.7M
Earning Date
04-30-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
39.15
N/A
EPS
N/A
N/A
Revenue
N/A
$502,076,000.00
Revenue This Year
$7.39
$89.45
Revenue Next Year
$6.00
$73.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
126.26
52 Week Low
$53.13
$42.09
52 Week High
$119.98
$84.94

Technical Indicators

Market Signals
Indicator
W
BBIO
Relative Strength Index (RSI) 63.99 74.78
Support Level $80.08 $62.39
Resistance Level $108.31 $79.57
Average True Range (ATR) 4.90 2.48
MACD 0.24 1.14
Stochastic Oscillator 73.30 91.21

Price Performance

Historical Comparison
W
BBIO

About W Wayfair Inc.

Wayfair engages in e-commerce in the United States (88% of 2025 sales), Canada, the United Kingdom, and Ireland. It's also embarked on expansion into the brick-and-mortar landscape, with 13 stores (excluding outlets) between the AllModern, Birch Lane, Joss & Main, and Wayfair banners. At the end of 2025, the firm offered more than 40 million products from more than 20,000 suppliers under the brands Wayfair, Joss & Main, AllModern, Birch Lane, and Perigold. Its offerings include furniture, everyday and seasonal decor, decorative accents, housewares, as well as advertising and logistics services. Wayfair was founded in 2002 and began trading publicly in 2014.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: